AU Stock MarketDetailed Quotes

TYP Tryptamine Therapeutics Ltd

Watchlist

0.044
+0.001+2.33%

20min DelayMarket Closed Nov 29 16:00 AET

56.16MMarket Cap-483P/E (Static)

Tryptamine Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Jun 30, 2020

(FY)Jun 30, 2019

Total revenue

520.24%618.57K

99.73K

Operating revenue

520.24%618.57K

--99.73K

----

Cost of revenue

Gross profit

520.24%618.57K

99.73K

Operating expense

-28.16%10.21M

12.20%14.21M

58.24%12.67M

237.52%8M

2.37M

Selling and administrative expenses

-32.85%6.5M

17.61%9.68M

71.73%8.23M

251.40%4.79M

--1.36M

-Selling and marketing expense

-67.66%93.8K

-12.35%290.07K

139.99%330.96K

--137.91K

----

-General and administrative expense

-31.77%6.41M

18.87%9.39M

69.71%7.9M

241.29%4.65M

--1.36M

Research and development costs

-31.67%1.73M

-19.93%2.54M

20.89%3.17M

427.34%2.62M

--496.69K

Depreciation amortization depletion

-1.56%1.7M

71.75%1.73M

163.16%1.01M

537.29%382.42K

--60.01K

-Depreciation and amortization

-1.56%1.7M

71.75%1.73M

163.16%1.01M

537.29%382.42K

--60.01K

Other operating expenses

2.71%276.74K

1.81%269.45K

25.35%264.65K

-53.21%211.14K

--451.28K

Operating profit

32.04%-9.59M

-11.41%-14.11M

-58.24%-12.67M

-237.52%-8M

-2.37M

Net non-operating interest income (expenses)

-300.58%-313.28K

-1,209.46%-78.21K

-88.36%7.05K

110.43%60.58K

28.79K

Non-operating interest income

494.44%17.95K

-57.17%3.02K

-88.36%7.05K

110.43%60.58K

--28.79K

Non-operating interest expense

307.79%331.23K

--81.23K

----

Other net income (expenses)

-32.44%2.77M

-2.03%4.11M

57.26%4.19M

2.67M

Other non-operating income (expenses)

-32.44%2.77M

-2.03%4.11M

57.26%4.19M

--2.67M

----

Income before tax

29.29%-7.13M

-19.08%-10.08M

-60.42%-8.47M

-131.23%-5.28M

-2.28M

Income tax

Earnings from equity interest net of tax

Net income

29.29%-7.13M

-19.08%-10.08M

-60.42%-8.47M

-131.23%-5.28M

-2.28M

Net income continuous operations

29.29%-7.13M

-19.08%-10.08M

-60.42%-8.47M

-131.23%-5.28M

---2.28M

Noncontrolling interests

Net income attributable to the company

29.29%-7.13M

-19.08%-10.08M

-60.42%-8.47M

-131.23%-5.28M

-2.28M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

29.29%-7.13M

-19.08%-10.08M

-60.42%-8.47M

-131.23%-5.28M

-2.28M

Diluted earnings per share

36.26%-0.0905

0.93%-0.142

-15.30%-0.1433

-39.45%-0.1243

-0.0891

Basic earnings per share

36.26%-0.0905

0.93%-0.142

-15.30%-0.1433

-39.45%-0.1243

-0.0891

Dividend per share

Accounting Standards

US-GAAP

	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Jun 30, 2020	(FY)Jun 30, 2019
Total revenue	520.24%618.57K	99.73K
Operating revenue	520.24%618.57K	--99.73K	----	----	----
Cost of revenue
Gross profit	520.24%618.57K	99.73K
Operating expense	-28.16%10.21M	12.20%14.21M	58.24%12.67M	237.52%8M	2.37M
Selling and administrative expenses	-32.85%6.5M	17.61%9.68M	71.73%8.23M	251.40%4.79M	--1.36M
-Selling and marketing expense	-67.66%93.8K	-12.35%290.07K	139.99%330.96K	--137.91K	----
-General and administrative expense	-31.77%6.41M	18.87%9.39M	69.71%7.9M	241.29%4.65M	--1.36M
Research and development costs	-31.67%1.73M	-19.93%2.54M	20.89%3.17M	427.34%2.62M	--496.69K
Depreciation amortization depletion	-1.56%1.7M	71.75%1.73M	163.16%1.01M	537.29%382.42K	--60.01K
-Depreciation and amortization	-1.56%1.7M	71.75%1.73M	163.16%1.01M	537.29%382.42K	--60.01K
Other operating expenses	2.71%276.74K	1.81%269.45K	25.35%264.65K	-53.21%211.14K	--451.28K
Operating profit	32.04%-9.59M	-11.41%-14.11M	-58.24%-12.67M	-237.52%-8M	-2.37M
Net non-operating interest income (expenses)	-300.58%-313.28K	-1,209.46%-78.21K	-88.36%7.05K	110.43%60.58K	28.79K
Non-operating interest income	494.44%17.95K	-57.17%3.02K	-88.36%7.05K	110.43%60.58K	--28.79K
Non-operating interest expense	307.79%331.23K	--81.23K	----	----	----
Other net income (expenses)	-32.44%2.77M	-2.03%4.11M	57.26%4.19M	2.67M
Other non-operating income (expenses)	-32.44%2.77M	-2.03%4.11M	57.26%4.19M	--2.67M	----
Income before tax	29.29%-7.13M	-19.08%-10.08M	-60.42%-8.47M	-131.23%-5.28M	-2.28M
Income tax	0	0	0	0	0
Earnings from equity interest net of tax
Net income	29.29%-7.13M	-19.08%-10.08M	-60.42%-8.47M	-131.23%-5.28M	-2.28M
Net income continuous operations	29.29%-7.13M	-19.08%-10.08M	-60.42%-8.47M	-131.23%-5.28M	---2.28M
Noncontrolling interests
Net income attributable to the company	29.29%-7.13M	-19.08%-10.08M	-60.42%-8.47M	-131.23%-5.28M	-2.28M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	29.29%-7.13M	-19.08%-10.08M	-60.42%-8.47M	-131.23%-5.28M	-2.28M
Diluted earnings per share	36.26%-0.0905	0.93%-0.142	-15.30%-0.1433	-39.45%-0.1243	-0.0891
Basic earnings per share	36.26%-0.0905	0.93%-0.142	-15.30%-0.1433	-39.45%-0.1243	-0.0891
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data